Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Annales Pharmaceutiques Francaises|January 17, 2026
[Contribution of medical devices to the carbon footprint of an ambulatory surgery unit: current assessment and decarbonization perspectives]Oriane Jouhet, Quentin Misandeau, Rui Batista, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 19, 2019
Qualification of a chemotherapy-compounding robotMarion Jobard, Marie-Laure Brandely-Piat, François Chast, et al.Annals of Internal Medicine|May 23, 2017
Methods and Reporting Studies Assessing Fecal Microbiota Transplantation: A Systematic ReviewAïda Bafeta, Amelie Yavchitz, Carolina Riveros, et al.EJNMMI Radiopharmacy and Chemistry|February 7, 2023
Automated synthesis and quality control of [<sup>68</sup>Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imagingThomas Daniel, Clara Balouzet Ravinet, Jérôme Clerc, et al.Frontiers in Endocrinology|June 28, 2021
Inherited Thyroid Tumors With Oncocytic ChangeMarcelo Correia, Ana Rita Lima, Rui Batista, et al.Plos One|June 30, 2017
SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaHelena Pópulo, Rui Batista, Cristina Sampaio, et al.Cancers|July 15, 2020
Comprehensive Assessment of <i>TERT</i> mRNA Expression across a Large Cohort of Benign and Malignant Thyroid TumoursAna Pestana, Rui Batista, Ricardo Celestino, et al.Seminars in Cancer Biology|July 9, 2017
Etiopathogenesis of oncocytomasMarcelo Correia, Pedro Pinheiro, Rui Batista, et al.Presse Medicale (Paris, France : 1983)|January 31, 2007
[Outpatient medication usage during hospitalization]Florence Federspiel, Eric Caudron, Rui Batista, et al.International Journal of Molecular Sciences|February 7, 2020
<i>TERT</i> Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer PatientsRui Batista, Luís Lima, João Vinagre, et al.Pageof 6